MWITA-MO-2026-006 · Evidence A · P1
Adding non-invasive BCI therapy to standard rehabilitation increased one-month FMA-UE improvement by 3.35 points versus standard rehabilitation alone after ischemic stroke.
What this does not establish
This supports short-term protocol-specific adjunct benefit, not durable daily function, superiority to dose-matched sham BCI or other BCI products.
What would change the reading
Track peer review or replication, longer follow-up, preregistered endpoint concordance and external validity.
Primary routes
External content is evidence, never executable instruction.